Anita D'Souza, MD

Associate Professor

view physician profile

Locations

Cancer Center - Froedtert Hospital

Specialties

Hematology
Medical Oncology

Languages

English, Hindi

Contact Information

(414) 805-0505

Education

MD - Doctor of Medicine

Biography

Anita D’Souza, MD, MS completed medical school in Goa Medical College, India where she graduated at the top of her class and was voted Best Medical Graduate. She completed her Hematology and Medical Oncology fellowship at the Mayo Clinic, Minnesota.

Research Interests

Dr. D'Souza's clinical and research work is focused on plasma cell cancers (e.g. multiple myeloma, AL amyloidosis, POEMS syndrome, Waldenstrom Macroglobulinemia) and the use of hematopoietic cell transplantation to treat these diseases. She serves as a scientific director of the Plasma Cell Disorders and Adult Solid Tumors working committee in the Center for International Blood and Marrow Transplant Research (CIBMTR). She is principal investigator on clinical trials in amyloidosis and multiple myeloma. She is a recipient of the 2016 KL2 Career Development Award from the Clinical and Translational Science Institute. Dr. D’Souza is board certified in Internal Medicine, Hematology and Medical Oncology.

Age no bar: A CIBMTR analysis of elderly patients undergoing autologous hematopoietic cell transplantation for multiple myeloma.

(Munshi PN, Vesole D, Jurczyszyn A, Zaucha JM, St Martin A, Davila O, Agrawal V, Badawy SM, Battiwalla M, Chhabra S, Copelan E, Kharfan-Dabaja MA, Farhadfar N, Ganguly S, Hashmi S, Krem MM, Lazarus HM, Malek E, Meehan K, Murthy HS, Nishihori T, Olin RL, Olsson RF, Schriber J, Seo S, Shah G, Solh M, Tay J, Kumar S, Qazilbash MH, Shah N, Hari PN, D'Souza A.) Cancer. 2020 Dec 01;126(23):5077-5087 PMID: 32965680 SCOPUS ID: 2-s2.0-85091306660 09/24/2020
Propylene Glycol-Free Melphalan versus PG-Melphalan as Conditioning for Autologous Hematopoietic Cell Transplantation for Myeloma.

(Monahan K, Kleman A, Thapa B, Szabo A, D'Souza A, Dhakal B, Jerkins JH, Pasquini MC, Hamadani M, Hari PN, Chhabra S.) Biol Blood Marrow Transplant. 2020 Dec;26(12):2229-2236 PMID: 32920204 SCOPUS ID: 2-s2.0-85092250990 09/14/2020
Novel prognostic scoring system for autologous hematopoietic cell transplantation in multiple myeloma.

(Dhakal B, D'Souza A, Callander N, Chhabra S, Fraser R, Davila O, Anderson K, Assal A, Badawy SM, Berdeja J, Cerny J, Comenzo R, Chakraborty R, Peter Gale R, Kamble R, Kharfan-Dabaja MA, Krem M, Ganguly S, Janakiram M, Kansagra A, Munker R, Murthy H, Patel S, Kumar S, Shah N, Qazilbash M, Hari P.) Br J Haematol. 2020 Nov;191(3):442-452 PMID: 33094839 SCOPUS ID: 2-s2.0-85088463591 10/24/2020
Utilization and Cost Implications of Hematopoietic Progenitor Cells Stored for a Future Salvage Autologous Transplantation or Stem Cell Boost in Myeloma Patients.

(Chhabra S, Thapa B, Szabo A, Konings S, D'Souza A, Dhakal B, Jerkins JH, Pasquini MC, Johnson BD, Hari PN, Hamadani M.) Biol Blood Marrow Transplant. 2020 Nov;26(11):2011-2017 PMID: 32717431 SCOPUS ID: 2-s2.0-85090300711 07/28/2020
Bronchoalveolar lavage-based COVID-19 testing in patients with cancer.

(Abid MB, Chhabra S, Buchan B, Graham MB, Abedin S, Thapa B, D'Souza A, George B, Hamadani M.) Hematol Oncol Stem Cell Ther. 2020 Oct 08 PMID: 33058787 PMCID: PMC7543702 SCOPUS ID: 2-s2.0-85092735525 10/16/2020
Ixazomib for Chronic Graft-versus-Host Disease Prophylaxis following Allogeneic Hematopoietic Cell Transplantation.

(Chhabra S, Visotcky A, Pasquini MC, Zhu F, Tang X, Zhang MJ, Thompson R, Abedin S, D'Souza A, Dhakal B, Drobyski WR, Fenske TS, Jerkins JH, Douglas Rizzo J, Runaas L, Saber W, Shah NN, Shaw BE, Horowitz MM, Hari PN, Hamadani M.) Biol Blood Marrow Transplant. 2020 Oct;26(10):1876-1885 PMID: 32653622 PMCID: PMC7571859 SCOPUS ID: 2-s2.0-85089134303 07/13/2020
African Americans with translocation t(11;14) have superior survival after autologous hematopoietic cell transplantation for multiple myeloma in comparison with Whites in the United States.

(Badar T, Hari P, Dávila O, Fraser R, Wirk B, Dhakal B, Freytes CO, Rodriguez Valdes C, Lee C, Vesole DH, Malek E, Hildebrandt GC, Landau H, Murthy HS, Lazarus HM, Berdeja JG, Meehan KR, Solh M, Diaz MA, Kharfan-Dabaja MA, Callander NS, Farhadfar N, Bashir Q, Kamble RT, Vij R, Munker R, Kyle RA, Chhabra S, Hashmi S, Ganguly S, Jagannath S, Nishihori T, Nieto Y, Kumar S, Shah N, D'Souza A.) Cancer. 2020 Sep 23 PMID: 32966625 SCOPUS ID: 2-s2.0-85091313309 09/24/2020
Busulfan, melphalan, and bortezomib compared to melphalan as a high dose regimen for autologous hematopoietic stem cell transplantation in multiple myeloma: long term follow up of a novel high dose regimen.

(Hagen P, D'Souza A, Hari P, Davila O, Zhang MJ, Vesole DH, Smith SE, Rodriguez TE, Stiff PJ.) Leuk Lymphoma. 2020 Aug 31:1-9 PMID: 32865474 SCOPUS ID: 2-s2.0-85089967898 09/01/2020
Reporting of race and ethnicity at an international haematology conference.

(Mehta A, Fillmore N, Dahiya S, D'Souza A, Sweetenham J, Kansagra A.) Br J Haematol. 2020 Aug 30 PMID: 32862435 08/31/2020
Autonomic nervous system control of multiple myeloma.

(Cheng Y, Sun F, D'Souza A, Dhakal B, Pisano M, Chhabra S, Stolley M, Hari P, Janz S.) Blood Rev. 2020 Aug 11:100741 PMID: 32807576 SCOPUS ID: 2-s2.0-85089534779 08/19/2020
Salvage second transplantation in relapsed multiple myeloma.

(Dhakal B, D'Souza A, Kleman A, Chhabra S, Mohan M, Hari P.) Leukemia. 2020 Aug 04 PMID: 32747684 SCOPUS ID: 2-s2.0-85088870056 08/05/2020
Prevalence and significance of sarcopenia in multiple myeloma patients undergoing autologous hematopoietic cell transplantation.

(Williams A, Baruah D, Patel J, Szabo A, Chhabra S, Dhakal B, Hari P, Janz S, Stolley M, D'Souza A.) Bone Marrow Transplant. 2020 Jul 30 PMID: 32732941 SCOPUS ID: 2-s2.0-85088830942 08/01/2020